A Stocktwits user expressed optimism for the stock, citing the three upcoming FDA applications. Another noted that the low cash reserve is expected in a company not selling products yet.

Ocugen (OCGN) is climbing 5% after investment bank H.C. Wainwright raised its price target on the shares to $8 from $7. OCGN, whose stock is currently trading around 69 cents, develops gene ...

In the latest trading session, Ocugen (OCGN) closed at $8.63, marking a -1.26% move from the previous day. This move lagged the S&P 500's daily loss of 0.54%. Meanwhile, the Dow gained 0.97% ...

StockTwits is unveiling a new feature called Conversations, which should make it easier to not just track the online discussion about a stock, but to join in, too. Co-founder and CEO Howard ...

Ocugen Inc OCGN shares traded marginally higher by 1.22% at $1.66 during Wednesday's after-hours session. The company announced during after-hours trading that the Independent Data and Safety ...

Ocugen shares are trading lower by 11% Thursday morning. The company announced the pricing of its public offering. Unlock your all-in-one trading dashboard with real-time alerts, rankings, and ...